News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
176 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (3339)
February (3294)
March (4068)
April (3458)
May (4782)
June (3455)
July (2690)
August (3589)
September (3334)
October (3977)
November (4082)
December (2500)
Day
1 (263)
2 (352)
3 (165)
4 (13)
5 (10)
6 (239)
7 (343)
8 (266)
9 (349)
10 (114)
11 (10)
12 (9)
13 (256)
14 (249)
15 (160)
16 (147)
17 (88)
18 (1)
19 (1)
20 (161)
21 (159)
22 (71)
23 (13)
24 (28)
26 (9)
27 (135)
28 (176)
29 (153)
30 (142)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
26
27
28
29
30
Business
Aro Biotherapeutics Secures $41.5M Series B Financing
Aro Biotherapeutics today announced it has secured $41.5M in a Series B funding round.
November 28, 2023
·
2 min read
BioMidwest
Obatala Sciences Announces Commercial Launch of Its ObaCell® Obesity-on-a-Chip Service
Obatala Sciences announced the accomplishment of a major milestone with the commercial launch of its ObaCell® Obesity-on-a-Chip Service.
November 28, 2023
·
4 min read
Pharm Country
New Study Found Preventive Impact in Adolescents Who Frequently Used Nerivio® for Abortive Treatment of Migraine
Theranica, a neuromodulation therapeutics company, announced the peer-reviewed publication of a comprehensive clinical study showing the preventive benefits of their REN wearable, Nerivio®, for adolescents suffering from migraine.
November 28, 2023
·
5 min read
Biotech Beach
Spinal Elements® Announces Full Commercial Release of Ventana® 3D-Printed Interbody Portfolio
Spinal Elements, a spine technology company, announced the full commercial launch of their Ventana 3D-Printed Interbody Portfolio: The Ventana C Anterior Cervical Interbody System, Ventana P/T Posterior Lumbar Interbody System and Ventana L Lateral Lumbar Interbody System.
November 28, 2023
·
3 min read
Business
Curative Appoints Brandon Charles as New Chief Medical Officer
Dr. Brandon Charles has joined Curative as its new Chief Medical Officer.
November 28, 2023
·
3 min read
BioMidwest
GE HealthCare Expands On-Device Triage Capabilities of Critical Care Suite with FDA Clearance of Algorithm for Pneumothorax Detection, Notification, Triage and Diagnosis
Today GE HealthCare (Nasdaq: GEHC) announced an industry-first US FDA 510K clearance of Critical Care Suite 2.1 featuring a Pneumothorax (PTX) algorithm for the detection, notification, triage and diagnosis of PTX.
November 28, 2023
·
5 min read
BioMark Provides Second Quarter Operational Update and Announces Extension to Warrant Exercise Term.
BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) (“BioMark” or the “Company”) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers today reports strong operational results
November 28, 2023
·
5 min read
CellChorus Appoints Andrew Last, PhD, to Board of Directors
CellChorus Inc., the leader in applying artificial intelligence to visually evaluate how cells perform and interact over time, announced the appointment of Andrew Last, PhD, to its board of directors.
November 28, 2023
·
1 min read
Drug Development
Coherus and Junshi Biosciences Announce Publication of Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Trial Evaluating LOQTORZI™ (toripalimab-tpzi) as Treatment for Nasopharyngeal Carcinoma, in the JAMA
Coherus BioSciences, Inc. and Shanghai Junshi Biosciences Co., Ltd announced the publication of the final overall survival results from the pivotal JUPITER-02 study.
November 28, 2023
·
25 min read
BioMidwest
Meridian Bioscience Earns EcoVadis Bronze Medal in Recognition of Its Dedication to Sustainability
Meridian Bioscience, Inc. has been awarded the distinguished EcoVadis Bronze Medal in recognition of the commitment to its sustainable business practices.
November 28, 2023
·
2 min read
Previous
6 of 18
Next